Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions



Status:Completed
Conditions:High Blood Pressure (Hypertension)
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 45
Updated:1/25/2018
Start Date:January 2005
End Date:January 2005

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ramipril 10 mg Capsules Under Fed Conditions

The objective of this study was to prove the bioequivalence of Ramipril 10 mg capsules under
fed conditions.


Inclusion Criteria:

- No clinically significant abnormal findings on the physical examination, medical
history, or clinical laboratory results during screening

Exclusion Criteria:

- Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme
altering drugs. History of allergic or adverse response to Ramipril or any comparable
or similar product.
We found this trial at
1
site
CEDRA Clinical Research, LLC
Austin, Texas
?
mi
from
Austin, TX
Click here to add this to my saved trials